Skip to main content
. Author manuscript; available in PMC: 2010 Sep 1.
Published in final edited form as: Cancer Res. 2009 Sep 1;69(17):6915–6923. doi: 10.1158/0008-5472.CAN-09-0664

Figure 6. SK1-I enhances survival of mice with LN229 cells implanted intracranially.

Figure 6

(A–D) LN229-H2B-GFP cells were implanted into the brain of nu/nu mice 1 mm lateral to the Bregma and at a depth of 3.5 mm. Twenty days later, tumor bearing mice were randomized into two groups and injected i.p. with saline or SK1-I (10 mg/kg) every other day until day 49. (A) Representative MRI images at day 48 are shown: T2-weighted images of vehicle and SK1-I treated animals. Note the dramatic effect of SK1-I on tumor growth compared to the massive tumor in untreated animal. (B) Contrast-enhanced T1-weighted image of SK1-I treated animal. (C) Kaplan Meier survival curves for animals implanted with LN229 cells treated with vehicle or SK1-I, as described above. (D) Intracranial tumors of vehicle and SK1-I treated animals were visualized by confocal microscopy for GFP expression (green) after counterstaining with Hoechst 33342 (blue). Representative sections at the site of injection are shown. Scale bars, 100 microns.

HHS Vulnerability Disclosure